CyDex Pharmaceuticals Presents Phase 2 Clinical Trial Results for Captisol-EnabledÂ® Budesonide/Azelastine Combination Solution Nasal Spray at American Academy of Allergy Asthma and Immunology (AAAAI) Meeting